88 results
Page 3 of 5
8-K
EX-99.1
3tivqwf w3yo9tr
3 Feb 21
Regulation FD Disclosure
12:00am
8-K
EX-99.1
kefkfu3chxb
2 Nov 20
Rhythm Pharmaceuticals Reports Third Quarter 2020 Financial Results
9:32am
8-K
EX-99.1
itfb2slmqvwb2ucdor3
3 Aug 20
Rhythm Pharmaceuticals Reports Second Quarter 2020 Financial Results
9:25am
8-K
EX-99.1
tpsd3ici
10 Jan 20
Regulation FD Disclosure
8:46am
8-K
EX-99.1
kepdatfzc2cmm
6 Nov 19
Rhythm Pharmaceuticals Announces Late-breaking Data from Phase 3 Trials of Setmelanotide in POMC and LEPR Deficiency Obesities at ObesityWeek 2019
9:28am
8-K
EX-1.1
qf9j54ui y8kmak7l0
16 Oct 19
Rhythm Pharmaceuticals, Inc. Announces Proposed Public Offering
5:27pm
424B5
lwkuusxz5 7aj35
16 Oct 19
Prospectus supplement for primary offering
5:25pm
424B5
hf1racys nx45x80cf9t
15 Oct 19
Prospectus supplement for primary offering
4:51pm
8-K
EX-99.1
pq433fu2
7 Aug 19
Other Events
9:07am
8-K
EX-99.2
kn6xu7x2opu8nqny k9
7 Aug 19
Other Events
9:07am
8-K
EX-99.1
llucn
29 Jul 19
Regulation FD Disclosure
4:40pm
8-K
EX-99.1
iozqm9
29 Jul 19
Rhythm Pharmaceuticals Reports Second Quarter 2019 Financial Results
4:40pm
8-K
EX-99.1
n4qrp7trm4kxvbw2
25 Jul 19
Rhythm Pharmaceuticals Announces Appointment of Stuart Arbuckle to its Board of Directors
4:01pm